Filter by: Subject

Now showing items 1-60 of 27

Efavirenz (2)
Excitotoxicity (2)
Polycyclic cage compounds (2)
Adverse pregnancy outcomes (1)
Affordable Care Act, Academy of Managed Care Pharmacies, American Pharmacists Association, Center for Biologics Evaluation and Research, Centers for Disease Control and Prevention (1)
African traditional medicine (1)
Antiretroviral agents (1)
Antiretroviral drug (1)
Antiretroviral therapy (1)
Antiretrovirals (1)
Apoptosis (1)
Birth defect (1)
Blood-brain barrier (1)
Botswana (1)
Calcium influx (1)
Competency framework (1)
Dissolution (1)
Drug design (1)
Economic conditions (1)
Education (1)
Emtricitabine (1)
Enantiopure Chirality Cost-effectiveness Efficacy Racemic, Regulatory, Omeprazole, someprazole, Citalopram, Escitalopram (1)
Epidemiology; Antimicrobial; Resistance; private sector; Health care (1)
Ethionamide (1)
First trimester (1)
Fixed-dose combination (1)
Freeze-dried aqueous extract (1)
HIV (1)
HIV treatment (1)
HPLC (1)
Human immunodeficiency virus (1)
Hygroscopicity (1)
Income (1)
Indigenous Knowledge Systems (IKS) (1)
Leonotis leonurus (1)
Liquid chromatography (1)
Low birth weight (1)
Marrubiin (1)
Mass spectrometry (1)
Multidrug-resistant tuberculosis (1)
Mycobacterium tuberculosis (1)
N-methyl-D-aspartate (NMDA) receptors (1)
Neurodegenerative diseases (1)
Neurodegenerative disorders (1)
Neuroprotection (1)
Nevirapine (1)
Nitric oxide (1)
NO-donating (1)
Oxidative stress (1)
Pharmaceutical manufacturing sector (1)
Pharmacokinetics (1)
Plasma concentrations (1)
Policy (1)
Post-market quality (1)
Pregnant women (1)
Preterm delivery (1)
Primary health care (1)
Prostate cancer (1)
Public health facilities (1)
Quality of life (1)